EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus

Rebekah M Ahmed, Nga Yan Tse, Martina Bocchetta, Carol Dobson-Stone, John B Kwok, John R Hodges, Muireann Irish, Jonathan R Rohrer, Olivier Piguet, Glenda Halliday

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Rebekah M Ahmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: C9orf72 Protein, Body Composition, Thalamus, Frontotemporal Dementia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Patients with sporadic frontotemporal dementia (FTD) display changes in metabolism and body composition. No studies have examined body composition changes in pre‐symptomatic C9orf72 mutation carriers METHODS Asymptomatic C9orf72 expansion carriers between 2017 and 2022 ( n = 28 non‐carriers, 16 expansion‐positive), underwent dual‐energy X‐ray absorptiometry (measurement of changes in body composition) and brain magnetic resonance imaging (MRI). RESULTS Changes in body composition were identified in the C9orf72 expansion carrier group compared to non‐carrier group (average 11–12 years prior to onset): lower android‐to‐gynoid ratio ( p = 0.009), and visceral adipose tissue area ( p = 0.010). Lower android‐to‐gynoid ratio and lean mass were associated with lower volumes across the cortex, subcortex, and thalamus. CONCLUSIONS The current study highlights that genetically at‐risk C9orf72 patients exhibit altered body composition. These findings align with the growing recognition that changes in genetic frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS) extend beyond cognitive/motor symptoms and include early alterations in broader physiological function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C9orf72 ProteinBody CompositionThalamusFrontotemporal DementiaHypothalamusHumansMagnetic Resonance ImagingFemaleMaleHeterozygoteMiddle AgedAbsorptiometry, PhotonAged

Stichwörter der Autor:innen

FTDgeneticmetabolismneurodegeneration

Substanzen

C9orf72 ProteinC9orf72 protein, human

Autor:innen und Institutionen

  • Brain and Mind Centre, The University of Sydney, Sydney, Australia.
  • Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • School of Medical Sciences, The University of Sydney, Sydney, Australia.
  • School of Psychology, The University of Sydney, Sydney, Australia.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Ahmed, R. M., Tse, N. Y., Bocchetta, M., Dobson-Stone, C., Kwok, J. B., Hodges, J. R., Irish, M., Rohrer, J. R., Piguet, O., & Halliday, G. (2026). Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71669

Vancouver

Ahmed RM, Tse NY, Bocchetta M, Dobson-Stone C, Kwok JB, Hodges JR, et al. Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71669

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Rebekah M and Tse, Nga Yan and Bocchetta, Martina and Dobson-Stone, Carol and Kwok, John B and Hodges, John R and Irish, Muireann and Rohrer, Jonathan R and Piguet, Olivier and Halliday, Glenda},
  title = {Changes in body composition in genetic C9orf72 carriers: The role of the hypothalamus and thalamus},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71669}
}
Kostenlos starten →